Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis

Abstract

Background

Endoscopic sleeve gastroplasty (ESG) is a minimally invasive, effective, and safe technique for weight loss intervention. Since a relatively small number of cases were present in previous studies, this study aimed to elucidate the efficacy and safety of ESG.

Methods

Relevant publications were identified through searching PubMed, EMBASE, Cochrane, and Web of Science before March 1, 2019. The percentage of total body weight loss (%TBWL), percentage of excess weight loss (%EWL), and the adverse event rate in each follow-up session were extracted, pooled, and analyzed. Forest plots were graphed based on random effects models.

Results

A total of 1542 patients from nine studies were eligible for analysis. The pooled results of %TBWL at 1, 3, 6, and 12 months were 8.78% (p = 0.000), 11.85% (p = 0.000), 14.47% (p = 0.024), and 16.09% (p = 0.063), respectively. The pooled results of %EWL at 1, 3, 6, and 12 months were 31.16% (p = 0.000), 43.61% (p = 0.000), 53.14% (p = 0.000), and 59.08% (p = 0.015), respectively. Finally, the pooled rate of mild adverse events was 72% (p < 0.01), and the pooled estimate of severe adverse events was only 1% (p = 0.08).

Conclusion

Although the conventional surgical sleeve gastrectomy is the gold standard for bariatric surgery, ESG could be a promising minimally invasive alternative for treating obesity with satisfactory efficacy and low risk.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Bray GA, Kim KK, Wilding JPH, World Obesity F (2017) Obesity: a chronic relapsing progressive disease process: a position statement of the World Obesity Federation. Obes Rev 18:715–723

  2. 2.

    Hiatt WR, Thomas A, Goldfine AB (2012) What cost weight loss? Circulation 125:1171–1177

  3. 3.

    Middleton KM, Patidar SM, Perri MG (2012) The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 13:509–517

  4. 4.

    Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR (2014) Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes. N Engl J Med 370:2002–2013

  5. 5.

    Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity 21(Suppl 1):S1–27

  6. 6.

    Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S (2015) ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82:425–438.e425

  7. 7.

    Hill C, Khashab MA, Kalloo AN, Kumbhari V (2018) Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci 1411:36–52

  8. 8.

    Kumbhari V, Hill C, Sullivan S (2017) Bariatric endoscopy: state-of-the-art. Curr Opin Gastroenterol 33:358–365

  9. 9.

    Yorke E, Switzer NJ, Reso A, Shi X, de Gara C, Birch D, Gill R, Karmali S (2016) Intragastric balloon for management of severe obesity: a systematic review. Obes Surg 26:2248–2254

  10. 10.

    Rohde U, Hedback N, Gluud LL, Vilsboll T, Knop FK (2016) Effect of the EndoBarrier gastrointestinal Liner ON obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 18:300–305

  11. 11.

    Abu Dayyeh BK, Rajan E, Gostout CJ (2013) Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 78:530–535

  12. 12.

    Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

  13. 13.

    Ginsberg GG, Chand B, Cote GA, Dallal RM, Edmundowicz SA, Nguyen NT, Pryor A, Thompson CC (2011) A pathway to endoscopic bariatric therapies. Gastrointest Endosc 74:943–953

  14. 14.

    Lopez-Nava G, Galvao MP, Bautista-Castano I, Jimenez-Banos A, Fernandez-Corbelle JP (2015) Endoscopic sleeve gastroplasty: how I do it? Obes Surg 25:1534–1538

  15. 15.

    Lopez-Nava G, Galvao MP, da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP (2015) Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy 47:449–452

  16. 16.

    Lopez-Nava Breviere G, Bautista-Castano I, Fernandez-Corbelle JP, Trell M (2016) Endoscopic sleeve gastroplasty (the Apollo method): a new approach to obesity management. Rev Esp Enferm Dig 108:201–206

  17. 17.

    Lopez-Nava G, Galvao MP, Bautista-Castano I, Fernandez-Corbelle JP, Trell M, Lopez N (2017) Endoscopic sleeve gastroplasty for obesity treatment: two years of experience. Arq Bras Cir Dig 30:18–20

  18. 18.

    Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK (2017) Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 27:2649–2655

  19. 19.

    Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ (2017) Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 15(37–43):e31

  20. 20.

    Sharaiha RZ, Kumta NA, Saumoy M, Desai AP, Sarkisian AM, Benevenuto A, Tyberg A, Kumar R, Igel L, Verna EC, Schwartz R, Frissora C, Shukla A, Aronne LJ, Kahaleh M (2017) Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 15:504–510

  21. 21.

    Novikov AA, Afaneh C, Saumoy M, Parra V, Shukla A, Dakin GF, Pomp A, Dawod E, Shah S, Aronne LJ, Sharaiha RZ (2017) Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg 22:267–273

  22. 22.

    Alqahtani A, Al-Darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M (2018) Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc 89(6):1132–1138

  23. 23.

    Fayad L, Adam A, Schweitzer M, Cheskin LJ, Ajayi T, Dunlap M, Badurdeen DS, Hill C, Paranji N, Lalezari S, Kalloo AN, Khashab MA, Kumbhari V (2018) Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc 89(4):782–788

  24. 24.

    Sartoretto A, Sui Z, Hill C, Dunlap M, Rivera AR, Khashab MA, Kalloo AN, Fayad L, Cheskin LJ, Marinos G, Wilson E, Kumbhari V (2018) Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg 28:1812–1821

  25. 25.

    Saumoy M, Schneider Y, Zhou XK, Shukla A, Kahaleh M, Aronne L, Sharaiha RZ (2018) A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc 87:442–447

  26. 26.

    Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, Sendra-Gutierrez JM, Gonzalez-Enriquez J (2008) Safety and effectiveness of the intragastric balloon for obesity: a meta-analysis. Obes Surg 18:841–846

  27. 27.

    Gaur S, Levy S, Mathus-Vliegen L, Chuttani R (2015) Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc 81:1330–1336

  28. 28.

    Moura D, Oliveira J, De Moura EG, Bernardo W, Galvao Neto M, Campos J, Popov VB, Thompson C (2016) Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis 12:420–429

  29. 29.

    Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT (2016) Current status of intragastric balloon for obesity treatment. World J Gastroenterol 22:5495–5504

Download references

Acknowledgements

Special thanks to Dr. Bin Ma for his selfless teaching and helping Dr. Peiwen Li to conduct this study.

Funding

This study was supported by the Natural Science Foundation of Liaoning Province (Grant No. 2015020561), the Fund for Scientific Research of The First Hospital of China Medical University (Grant No. fsfh1514), and Wu Jieping Medical Foundation (Grant No. 320.6750.18293).

Author information

Correspondence to Wenya Li.

Ethics declarations

Disclosures

Dr. Peiwen Li, Dr. Bin Ma, Dr. Shulei Gong, Dr. Xinyu Zhang, and Dr. Wenya Li have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, P., Ma, B., Gong, S. et al. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc 34, 1253–1260 (2020). https://doi.org/10.1007/s00464-019-06889-6

Download citation

Keywords

  • Endoscopic sleeve gastroplasty
  • Bariatric surgery
  • Endoscopic bariatric therapy
  • Sleeve gastroplasty